The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

The Truveta team at its Bellevue, Wash., headquarters last year. (Truveta Photo) Seattle-area health data company Truveta ...

A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will ...

Seventeen health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence and ...

The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...

Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of ...

Regeneron Pharmaceuticals (REGN) announced a strategic collaboration with Truveta and its collective of U.S. health systems to advance ...

The company said Monday that it will provide a $119.5 million investment in Truveta's Series C financing round and help launch the company's Truveta Genome Project, which will extend Regeneron's ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest and most diverse database of genetic information in the ...

NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...